Navigation Links
Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
Date:2/24/2009

SAN FRANCISCO, Feb. 24 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will hold a teleconference and webcast of a slide presentation on Wednesday, February 25, at 4:30 p.m. Eastern Time to discuss new efficacy and safety data from the ongoing Phase 1-2 clinical trial of the Company's novel androgen receptor antagonist MDV3100 in castration-resistant prostate cancer patients.

Howard Scher, M.D., principal investigator of the trial and chief of the Genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center, will participate in the teleconference. He will discuss the new MDV3100 data, as well as recent research regarding the association between changes in the number of circulating tumor cells (CTCs) and the prediction of survival and response to treatment in patients with advanced prostate cancer.

Teleconference/Webcast Details

To participate in the live call on Wednesday, February 25, at 4:30 p.m. Eastern Time by telephone, please dial 877-719-9810 from the U.S. or +1-719-325-4785 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A slide presentation that will accompany the teleconference can be accessed via the Web by accessing the webcast and will also be posted as a PDF next to the event listing in the Investor section of the Medivation website. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to trans
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Medivation Announces Participation in Upcoming Conferences
2. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
3. Medivation Announces Participation in Upcoming Conferences
4. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
5. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
6. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
7. drugstore.com, inc. to Present at the Upcoming Jefferies 5th Annual Internet & Media Conference
8. Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
9. Case Management Society of America Hosting Conference on Health Care Case Management
10. Service Corporation International Announces Schedule for Its Fourth Quarter 2008 Earnings Release and Conference Call
11. Nationwide to Present at Citigroup Global Property CEO Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... December 19, 2014 Eufaula, Oklahoma, located ... Lake Eufaula, the state’s largest lake with more than ... is home to a little more than 3,000 residents, ... on Saturday, the 6th of December. , Featuring Santa, ... through downtown Eufaula on Main Street. Narconon Arrowhead’s ...
(Date:12/19/2014)... 2014 The Medspa at Hendrick in ... from respected cosmetic brand Juvéderm. Voluma XC treats volume ... The Medspa at Hendrick is pleased to be able ... technology to its clients. , Voluma is the first ... to treat the mid-face and cheek area. This non-invasive ...
(Date:12/19/2014)... 2014 (HealthDay News) -- The intestinal bacteria that cause ... colitis, may be inherited, researchers report. The findings, ... could help in efforts to prevent the disease and ... the study authors added. "The intestinal bacteria, or ... can have a big impact on your health for ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Injectable drug users who also ... attempt rate of other substance users, a new study ... with the risk of suicide attempt and completed suicide," ... Montreal, said in a university news release. "However, there ... to know who among substance users were actually more ...
(Date:12/19/2014)... (HealthDay News) -- Older adults who have lost all their ... people who still have at least some of their teeth, ... tooth loss could provide an early warning of increased risk ... researchers said. However, the findings don,t prove that tooth ... included more than 3,100 participants 60 and older. People with ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2
... The Emergency Nurses Association (ENA) today announced the corporate ... Reno, Nevada on March 4 - 8, 2009.This year,s sponsors ... so pleased that these two companies have chosen to support ... the ENA Leadership Conference," said William T. Briggs, RN, MSN, ...
... Home Safety Council(R) and H2otStop(R) Launch Burn Awareness Campaign to ... , WASHINGTON, Feb. 9 New research conducted by ... while most adults in America (82 percent) agree that there ... burns in their home, nearly half (44 percent) say they ...
... be weighed against downside, experts say , , MONDAY, ... containing corticosteroids to treat chronic obstructive pulmonary disease (COPD) ... as 70 percent, researchers report. , Inhaled corticosteroids, used ... COPD patients. However, one product that is marketed by ...
... of 50 genes can be used to reliably identify ... research conducted at Washington University School of Medicine in ... oncologists can potentially predict the most effective therapy for ... treatment for all patients., "Unlike a widely used genomic ...
... WASHINGTON, Feb. 9 The Department of Veterans Affairs (VA) ... called a "Step-Up" -- from March 8 to 14 at ... follow the highest standards for patient safety."The safety of our ... J. Kussman, VA,s Under Secretary for Health. "Therefore, I am ...
... LAIYANG, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- Genesis,Pharmaceuticals ... or the,"Company"), a U.S. pharmaceutical company with ... China, today announced that the American Arbitration,Association ... Capital Research,Group, Inc. ("CRG") to award it ...
Cached Medicine News:Health News:Emergency Nurses Association Announces Corporate Sponsors for Leadership Conference 2Health News:American Families Unaware of Burn Dangers at Home 2Health News:American Families Unaware of Burn Dangers at Home 3Health News:American Families Unaware of Burn Dangers at Home 4Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 2Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 3Health News:Inhaled Corticosteroids Boost Pneumonia Risk in COPD 4Health News:New genomic test can personalize breast cancer treatment 2Health News:New genomic test can personalize breast cancer treatment 3Health News:Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis 2Health News:Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis 3
(Date:12/19/2014)... Friday, December 19 edition of USA ... features Konica Minolta, the company announced today. The supplement will focus ... organizations. In addition to the print section that ... New York , Chicago , ... Minneapolis and San Francisco , a ...
(Date:12/19/2014)... TODAY, AEGATE, the leader in medicine verification ... of Peter Fox as Chief Technology Officer ... Officer. Peter has served as Development Director ... Oracle in 2011. Prior to Datanomic, Peter ... and subsequently Convergys, a world renowned billing system for ...
(Date:12/19/2014)... , Dec. 19, 2014  Newport Corporation ... Siddhartha Kadia, Ph.D. has joined the company,s Board ... Executive Officer and a director of Evans Analytical ... testing, evaluation and analytical services to companies in ... Prior to joining Evans Analytical Group, Dr. Kadia ...
Breaking Medicine Technology:USA Today Supplement Featuring Konica Minolta Focuses on Impact of Healthcare IT 2Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... FOREST, Ill., March 9, 2011 Hospira, Inc. (NYSE: ... today announced U.S. Food and Drug Administration (FDA) approval of ... and Hospira expects to launch the product later this month. ... a variety of cancers. In 2010, U.S. sales of Taxotere ...
... Tris Pharma, a specialty pharmaceutical company that develops ... US Food and Drug Administration (FDA) has accepted ... the treatment of allergies in kids two years ... Suspension will provide an alternative to the currently ...
Cached Medicine Technology:Hospira Announces U.S. Approval of Generic Docetaxel 2Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older 2
Stainless steel threaded Steinman Pins available in point types A,D, E, and F....
Full pin skeletal traction pins with cove point....
Round Bevel-Point Hook Pin available in 2.3mm, 3.1mm, 4.7mm, and 6.3mm sizes....
... available in two point styles with standard ... DePuy certified stainless steel. (sold in packs ... in 1/2 in. increments from 3 in. ... in 1/2 in. increments with lines and ...
Medicine Products: